logo

CERE(Delisted)

Cerevel TherapeuticsยทNASDAQ
--
--(--)

CERE Profile

Cerevel Therapeutics Holdings, Inc.

A clinical-stage neuroscience diseases biopharmaceutical company

--
--
07/30/2020
NASDAQ Stock Exchange
334
12-31
Common stock
222 Jacobs Street, Suite 200, Cambridge, MA 02141
--
Cerevel Therapeutics Holdings, Inc., is a Delaware corporation. The company is a clinical-stage biopharmaceutical company that combines a deep understanding of disease-related biology and brain neural circuits with advanced chemistry and central nervous system (CNS) targeting receptor selective pharmacology to discover and design new therapies.